Welcome to My Blog
Here is a masonry blog layout with no sidebarBanks need to hire chief risk officers to deal with cybercrimes: Deloitte
“…these (cyber) attacks are becoming complex day by day. To address these challenges, banks need to appoint experienced Chief Risk Officers who can take the responsibility of skilling the employees and lead investment in military-grade cybersecurity solutions to detect the most advanced attacks,” said the Deloitte report on “Digitizing the post COVID world: The ‘3I’ approach”.
Economy to reach pre-Covid-19-levels by end of FY2022: Niti Aayog
Foreign funds colonising Indian startups: Naukri.com founder Bikhchandani
Internet entrepreneur Sanjeev Bikhchandani says an estimated Rs 17 trillion of market cap has been transferred abroad after young Indian start-ups were forced to shift their company domicile overseas by foreign investors promising the funds they need for growth.
“Shades of the East India Company type of situation here – Indian market, Indian customers, Indian developers, Indian workforce. However 100% foreign ownership, foreign investors. IP and data transferred overseas. Transfer pricing issues foggy,” Internet entrepreneur Sanjeev Bikhchandani tweeted.
AstraZeneca and Oxford’s stories clash on COVID-19 vaccine
The discrepancy, reported for the first time by Reuters, centres on the regimen administered to a smaller group of volunteers in the late-stage trials, of half a dose followed by a full dose. This diverged from the original plan of two full doses, given to the majority of participants.
The half-dose pattern was found to be 90% effective, versus the 62% success rate of the two-full-dose main study, based on interim data
Job cuts, salary adjustments in COVID-19 aftermath not as widespread as expected: Report
“Despite the severe impact on revenue and cash, very surprisingly, the display of compassion and community outreach have produced a spontaneous level of commitment and loyalty from employees and job cuts and salary adjustments have not been as widespread an occurrence as originally apprehended,” said the report.
Volkswagen CEO expects autonomous cars on market from 2025-2030
4 of 5 cyclones this year were in severe cyclonic storms category and above
Value Of LIC’s equity holdings rallies 40% in h1 to Rs 5.7 lakh crore
As against this, domestic institutional investors’ holdings in the BSE-200 Index slipped to 13.6 percent in Q2 from 14 percent in Q1, as they sold shares worth Rs 63,500 crore since April. As of July-September, the value of LIC’s holdings in top 200 stocks stood at $77 billion.
During the first half of FY2021, value of LIC’s holding surged over 40 percent, or by $22 billion to $77 billion and LIC is said to have pumped Rs 55,000 crore into the equity market since April, as against Rs 32,800 crore in the year-ago period.
Approval from IRDAI on Axis Bank stake hike expected by March: Max Life CEO
“Under the revised agreements, Axis Bank will acquire up to 9.002 percent of the equity share capital of Max Life, and Axis Capital Limited and Axis Securities Limited will together acquire up to 3 percent of the share capital of Max Life.
“In addition, Axis entities will have a right to acquire an additional stake of up to 7 percent of the equity share capital of Max Life, in one or more tranches, in accordance with existing laws and regulations,” the bank had said.
India should begin scaling up syringe stocks for Covid vaccination: Experts
According to Rajiv Nath, Managing Director of Hindustan Syringes & Medical Devices Ltd, the estimated demand in India would be around 900 million pieces of different kinds of syringes for just one shot of the vaccine, considering 60-70 per cent of the country gets vaccinated.
“The number would amplify to 1.8 billion if the vaccine India chooses needs two shots,” Nath told IANS.
Britain gets ready for roll-out of Pfizer’s COVID-19 vaccine this week
Some of the most famous figures in British life stepped forward to say that they would receive the vaccine to encourage the public to follow suit. That could include Queen Elizabeth II and her husband Prince Philip, who are likely to receive the vaccine within weeks, according to MailOnline reports on Sunday.
India’s Serum Institute seeks emergency use nod for AstraZeneca’s COVID-19 vaccine
Almost all COVID-19 patients develop antibodies: WHO
“What we understand is 90 to 100 per cent of people who are infected with the virus do develop an antibody response, whether you have mild infection or asymptomatic infection all the way to severe infection. And we’re still learning how long that antibody response lasts, how strong it is, how it relates to immunity from another infection, and how long that lasts,” Van Kerkhove, an expert on epidemiology, said at a virtual press briefing.
US, Norwegian investors pressure SBI over loan to Adani mine in Australia
BlackRock, which holds shares of both Adani and SBI, has met with the companies tied to the Carmichael project and raised its objections because the plan has ESG-related risks, according to a person familiar with the matter, who declined to be identified because the conversations are private. In February, BlackRock rebuked Siemens AG for similar reasons when it signed an 18 million-euro ($21.8 million) contract to provide rail-signaling systems for the mine.
Moscow rolls out Sputnik V COVID-19 vaccine to most exposed groups
Now that vaccines are coming, what about poor countries?
By Andreas Kluth It’s now just a matter of weeks before shoulders are bared, syringes primed and vaccines injected. If last year was the one that gave Covid-19 its name and 2020 was defined by masks, gowns and swabs, 2021 will be the year of the...
Bharat Biotech says COVAXIN efficacious, safe, as Anil Vij tests positive for Covid-19
The drug firm said its vaccine Covaxin is based on two dose schedule and its efficacy is determined 14 days post the second dosage. “COVAXIN clinical trials are based on a 2-dose schedule, given 28 days apart. The vaccine efficacy will be determined 14 days post the second dose,” Bharat Biotech said in a statement.